Posted by: Thixia | May 23, 2008

Autoimmunity Interfering with Inflammation

Autoimmunity Interfering with Inflammation


Multiple sclerosis (MS) is an inflammatory autoimmune disease of the central nervous system (CNS), which causes demyelination of axons. Experimental autoimmune encephalomyelitis (EAE) is a mouse model of MS that is induced by immunizing mice with myelin oligodendrocyte glycoprotein (MOG). One of the best-known treatment for MS is the type I interferon (IFN), IFN-β; however, the mechanism of action is unclear.


Prinz et al. found that the abundance of IFN-β was increased in the CNS of MOG-treated mice compared with untreated mice, as measured by enzyme-linked immunosorbent assays, suggesting that local, but not systemic, IFN-β abundance is important in this disease. Treatment of mice deficient in the type I IFN receptor (Ifnar–/– mice) with MOG resulted in worse disease and increased mortality compared with MOG-treated wild-type mice.


Histological examination revealed that MOG-treated Ifnar–/– mice had more infiltrating myeloid cells, which included macrophages and microglia, in their spinal cords than did MOG-treated wild-type mice. The authors bred strains of mice that were Ifnar-deficient in specific cell types and exposed them to MOG.  


Whereas deletion of Ifnar in CD4+ T cells, B cells, astrocytes, or oligodendrocytes had little or no effect on disease outcome, deletion of Ifnar in myeloid cells led to exacerbated disease and increased mortality compared with that in wild-type mice. This was associated with the increased uptake of degraded myelin protein by Ifnar-deficient myeloid cells and the increased abundance of the proinflammatory cytokine tumour necrosis factor- and the chemokine CCL2, which recruits myeloid cells.


As Axtell and Steinman discuss, this study suggests that IFN-β acts on myeloid cells in the CNS to suppress inflammation and the processing of antigenic peptides, which would otherwise exacerbate disease by activating infiltrating T cells and causing further inflammation.




John F. Foley


Science Signaling, AAAS, Washington, DC 20005, USA



Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s


%d bloggers like this: